Informations:
Erreur:
ID
22012
Description
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin; ODM derived from: https://clinicaltrials.gov/show/NCT00691912
Lien
https://clinicaltrials.gov/show/NCT00691912
Mots-clés
Versions (1)
- 14/05/2017 14/05/2017 -
Téléchargé le
14 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Metastatic Breast Cancer NCT00691912
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
metastatic breast cancer, gender, age
Item
women >/= 18 years with histologically proven metastatic breast cancer
boolean
C0278488 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0079399 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
prior chemotherapy
Item
no prior chemotherapy in the advanced situation
boolean
C1514457 (UMLS CUI [1])
ecog
Item
ecog </= 2
boolean
C1520224 (UMLS CUI [1])
bone marrow reserve
Item
adequate bone marrow reserve
boolean
C0221130 (UMLS CUI [1])
left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) >/= 50, measured within 4 weeks before study treatment
boolean
C0428772 (UMLS CUI [1])
informed consent
Item
existence of written informed consent
boolean
C0021430 (UMLS CUI [1])
high dose therapy with stem cell support
Item
previous high dose therapy with stem cell support
boolean
C1512429 (UMLS CUI [1])
cumulative anthracycline dose, epirubicin, doxorubicin, mitoxantrone
Item
prior adjuvant treatment with cumulative anthracycline dose of 600 mg/m² epirubicin, 300 mg/m² doxorubicin, 80 mg/m² mitoxantrone
boolean
C2986497 (UMLS CUI [1,1])
C0282564 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0026259 (UMLS CUI [1,5])
C0282564 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0026259 (UMLS CUI [1,5])
concomitant hormone, chemo-, radiotherapy
Item
concomitant hormon- or chemotherapy or radiation therapy
boolean
C1707479 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0279025 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
her2 neu
Item
her2/neu overexpression
boolean
C1512413 (UMLS CUI [1])
pregnancy, breast feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])